Table 3 Experts consensus in Delphi study
From: A Delphi study for setting up tobacco research and practice network in India
Strong consensus | Consensus (agreement in %) | Inter quartile range |
|---|---|---|
Focus of TRNI | >75 % | 1 |
Tobacco cessation | >75 % | 1 |
Economic research | >75 % | 1 |
Implementation of tobacco control policy | ||
Sharing best practices | >75 % | 1 |
Advocacy | >75 % | 1 |
Financial sustainability | ||
Funds from government | >75 % | 1 |
Network members | ||
Government | >75 % | 1 |
NGOs | >75 % | 1 |
Academia | >75 % | 0.25 |
Factors holding back research dissemination | ||
Lack of funds | 0 | |
Benefits of the network | ||
Information sharing | >75 % | 1 |
Technical support | >75 % | 1 |
Moderate consensus | ||
Focus of TRNI | ||
Disease research | 60–74 % | 1 |
Implementation of tobacco control policy | ||
Consensus building | 60–74 % | 2 |
Establishing standard protocols | 60–74 % | 1 |
Factors holding back research | ||
Lack of technical expertise | 60–74 % | 2 |
Financial sustainability | ||
Funds from International organizations | 60–74 % | 1 |
Involvement of private sector and pharmaceutical companies | ||
Private sector should be involved with caution | 60–74 % | |
Benefits of the network | ||
Evidence-based policy implementation | 60–74 % | |
No consensus | ||
Factors holding back research | ||
Lack of emphasis on tobacco control | <60 % | 2 |
Lack of platform/forum | <60 % | 2 |
Financial sustainability | ||
Nominal membership fees | <60 % | 3 |
Involvement of private sector and pharmaceutical companies | ||
Private sector can be in involved in the network | <60 % | 2 |
Pharmaceutical companies should be involved with caution | <60 % | 2 |
Private sector and pharmaceutical companies should not be involved in the network | <60 % | 2 |
Benefits of the network | ||
Consensus building | <60 % | 2 |